SummaryMilliman, Inc., a premier global consulting and actuarial firm, announced Tuesday the acquisition of SkySail Rx, a pharmacy benefit technology firm that specializes in leveraging data for all aspects of pharmacy benefit pricing and contract management. The addition gives Milliman’s clients a more robust platform for managing pharmacy benefits and complements the firm’s existing suite of analytic tools.
RxBenefits, the employee benefits industry’s first and only technology-enabled pharmacy benefits optimizer (PBO), today announced it has completed its previously announced acquisition of Confidio, a pharmacy benefits consulting firm. RxBenefits and Confidio are both focused on solving a persistent industry issue – how to best maintain the affordability of a robust and competitive pharmacy benefit, complimented by an exceptional service experience.
Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), a pioneer with a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of services and product innovation, today announced the signing of non-binding Letters of Intent (“LOI”) to acquire seven pharmacies in the United States. The proposed all-stock transactions contemplate the acquisition, by Novo, of a 50% interest in each pharmacy.
A sale process has kicked off for BioMatrix, a private equity-backed national provider of specialty pharmacy and home infusion services, according to four sources familiar with the matter. Cantor Fitzgerald is running the process, which is in its early stages, sources said. ACON Investments, a Washington, DC-based international mid-market private equity firm, completed its acquisition of BioMatrix in November 2016.
Digital healthcare leader Pack4U acquires virtual pharmacist services company CHC Health, adding 400+ clinical pharmacists skilled in virtual monitoring and data analysis, performing more than seven million patient outreaches annually. The acquisition adds capacity to Pack4U’s pharmacist-powered model of team-based, personalized care that improves patient health outcomes at scale. Pack4U Inc is a digital healthcare company that optimizes prescribed medications.
This year has proven to be one of significant clinical importance—from successful COVID-19 vaccine distribution to a robust drug development pipeline approaching a new record high. As pharmacies continue to be the most frequent touchpoint in health care, clients, payers and providers are looking to the health care industry for solutions that improve health outcomes for patients while lowering costs. Here, OptumRx’s Chief Medical Officer examines several areas that have impacted the industry and forecasts where it is headed.
Medivolve, Inc. (“Medivolve” or the “Company”) (NEO: MEDV) (OTC: COPRF) (FRA: 4NC), a healthcare technology and services company, is pleased to announce on August 13, 2021, it closed the previously announced acquisition of Marbella (“Marbella” or the “Pharmacy”), an open-door retail pharmacy. Located in San Juan Capistrano, California, Marbella specializes in traditional medication and non-sterile compounded products, immunizations, and specialty and maintenance medications. Marbella also provides no cost door-to-door prescription delivery service and is reputed for servicing the underserved and worker’s compensation patients.
Generational Equity is pleased to announce the sale of its client, MediSuite, LLC to ADDvise Group AB. The acquisition closed August 4, 2021. Located in Cary, North Carolina, MediSuite is a national, mail-order pharmacy, MediSuite provides men’s health generic drugs at significant cost savings. MediSuite only dispenses FDA-approved pharmaceuticals. MediSuite’s most popular drugs are the generics of Viagra® (Sildenafil) and Cialis® (Tadalafil). ADDvise Group AB, (ADDvise) headquartered in Stockholm, Sweden is a leading supplier of equipment and services to healthcare and research facilities.
Pharmacies are at center stage in the U.S. health care market given their role in dispensing medications and, during the COVID-19 pandemic, administering vaccines. Understanding the dynamics among pharmacy types and what lies ahead for this industry is critical for U.S. policymakers considering policies aimed at increasing the cost-effectiveness and affordability of prescription drugs.
RxBenefits, a leading technology-enabled pharmacy benefits optimizer (PBO), has announced an agreement to acquire pharmacy benefits consulting firm, Confidio, pending regulatory approval. The pending transaction will bring together two premier, complementary providers of pharmacy benefits services, significantly expanding the combined company’s ability to lower pharmacy benefits costs for self-funded employers and plan sponsors, regardless of group size.
We publish a Daily Note that aggregates M&A activity, notable developments, regulatory changes, and conferences we deem to be of interest to our partners. It is a quick afternoon read and an easy way to keep your finger on the pulse of the healthcare space. Please fill in your name and email address below if you wish to subscribe.